13th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 1998

January 24-31, 1998
Marilleva, Trento, Italy

RT-126

Molecular diagnosis of inherited cardiac diseases: impact on clinical practice

Silvia G. Priori, Carlo Napolitano.
Laboratori di Cardiologia Molecolare ed Elettrofisiologia, Fondazione Salvatore Maugeri, Pavia, Cattedra di Cardiologia, Facolta di Medicina e Chirurgia, Universita degli Studi di Pavia, Policlinico San Matteo IRCCS, Pavia, Italy

Abstract

Molecular genetics is progressively entering clinical practice. This new approach is modifying medical thinking as it becomes possible to diagnose diseases in their pre-symptomatic phase. It is therefore important for physicians to become acquainted with the "language" and the "methodology" of molecular biologists in order to balance opposite attitudes of the novice, ie skepticism and over-expectation, and to establish a fruitful interaction with the molecular diagnostic laboratories.

There are conditions such as long QT syndrome and hypertrophic cardiomyopathy where knowledge is rather advanced and therefore clinical value of molecular diagnosis is proven. For other conditions such as arrhythmogenic right ventricular dysplasia, familial atrial fibrillation and familial Wolf Parkinson White only the chromosomal region where the gene is most likely located is known. In this cases the clinical value is limited by the fact that only relatively large families can be studied. Collaboration of physicians and basic scientists is warranted to develop molecular diagnosis into a clinical tool.

Key Words

Molecular biology - structural anatomy, pathology  
congenital cardiac diseases, gene disease, long QT syndrome, hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia, famial aftrial fibrillation, familial WPW syndrome, familal heart block, idiopathic ventricualr fibrillation, Brugada´s syndrome, R

 

forward

CARDIOnet® - registered trade mark name
Copyright © 1996-1998 by CARDIOnet. All rights reserved.